Professor David Hammond

Please note registrations close at midnight, Wednesday 29 July.

The ASPIRE2025 Centre is delighted to welcome international researcher, Professor David Hammond, from the University of Waterloo in Canada for this webinar presentation.

Our webinars address questions that should be of particular interest to people in the public health and smokefree sectors, and others interested in public health policy.

For this second webinar in the series, Professor Hammond will outline what New Zealand may learn from Canada’s evolving nicotine and cannabis regulations.

OVERVIEW

Canada provides one of the most interesting natural experiments in vaping regulation. Prior to 2018, Canada had a highly restricted market, in which nicotine-containing e-cigarettes were not approved for legal sale or marketing. However, a federal act in May 2018 liberalized the market, such that it was closer to the US e-cigarette market. Following increases in youth vaping, federal and provincial regulations are now moving back towards a more restricted market, including comprehensive bans on marketing, nicotine limits, flavour bans, and restrictions on retail access. The presentation will examine trends in vaping among adults and youth in Canada, including data from the ITC Youth surveys, with comparative trends between Canada, England, and the US.

The talk will also examine recent trends in vaping cannabis and THC oils –and the overlap between the nicotine and cannabis markets—following legalization of recreational cannabis in Canada in 2018/19. The discussion will consider implications for nicotine and cannabis policies in New Zealand.

SPEAKER – PROFESSOR DAVID HAMMOND

Professor David Hammond is an award winning tobacco control researcher from the School of Public Health and Health Systems, University of Waterloo in Canada.

We encourage you to take a look at his bio here.

REGISTRATION

Please note registrations close at midnight, Wednesday 29 July.

To register for this event and to confirm that you do not have any of the affiliations outlined below, please complete your registration here.

Once your registration has been approved, you will be emailed the access details and a link to the webinar.

WHO SHOULD ATTEND?

We welcome registration from people in the public health and smokefree sectors, and others interested in public health policy.

Please note: ASPIRE seminars, webinars and other events are not open to individuals working with or for any tobacco company, or who are affiliated to the tobacco industry in any way. Nor are they open to any individuals or groups who have interests in or relationships with tobacco companies, including, but not limited to, the Foundation for a Smoke-Free World (FSFW) and FSFW grantees. This webinar also addresses the use of cannabis by young people and is not open to organisations with a commercial interest in the legislation of cannabis.

Please note the additional detail provided below.

“Tobacco industry” refers to: a) any tobacco or tobacco product manufacturer, processor, wholesale distributor, importer, (and specialist tobacco retailers), b) any parent, affiliate, branch, or subsidiary of a tobacco or tobacco product manufacturer, wholesale distributor, importer, ​specialist tobacco retailer, or c) any individual or entity, such as, but not limited to an interest group, think tank, advocacy organization, lawyer, law firm, scientist, lobbyist, public relations and/or advertising agency, business, or foundation, that represents or works to promote the interests of the tobacco industry, or that receives or has received, either directly or indirectly, funding from a tobacco company or companies.

FOR MORE INFORMATION

Professor Richard Edwards
University of Otago, Wellington
Email: richard.edwards@otago.ac.nz

Issue date